Great-West Lifeco (TSE:GWO) had its price target increased by research analysts at Scotiabank from C$38.00 to C$40.00 in a report issued on Monday, BayStreet.CA reports. Scotiabank's price objective would suggest a potential upside of 7.01% from the company's previous close.
A number of other equities research analysts have also commented on the stock. CIBC upped their price target on shares of Great-West Lifeco to C$41.00 and gave the company a "neutral" rating in a report on Thursday. National Bank Financial set a C$37.00 price target on shares of Great-West Lifeco in a report on Friday. Royal Bank of Canada restated a "sector perform" rating and issued a C$39.00 price objective on shares of Great-West Lifeco in a report on Thursday. BMO Capital Markets upped their price objective on shares of Great-West Lifeco from C$37.00 to C$39.00 and gave the stock a "market perfom" rating in a report on Thursday. Finally, Credit Suisse Group upped their price objective on shares of Great-West Lifeco to C$37.00 and gave the stock a "neutral" rating in a report on Wednesday, May 12th. Five equities research analysts have rated the stock with a hold rating, The stock currently has an average rating of "Hold" and a consensus target price of C$37.25.
Shares of GWO traded up C$0.14 during mid-day trading on Monday, reaching C$37.38. The company's stock had a trading volume of 120,005 shares, compared to its average volume of 1,464,025. The firm has a market capitalization of C$34.70 billion and a PE ratio of 10.48. The company has a debt-to-equity ratio of 34.56, a quick ratio of 21.56 and a current ratio of 25.23. Great-West Lifeco has a 52 week low of C$23.55 and a 52 week high of C$38.00. The stock's fifty day moving average price is C$36.87.
Great-West Lifeco (TSE:GWO) last announced its quarterly earnings data on Wednesday, May 5th. The company reported C$0.76 earnings per share for the quarter, missing the Zacks' consensus estimate of C$0.78 by C($0.02). The firm had revenue of C$12.12 billion for the quarter. As a group, sell-side analysts expect that Great-West Lifeco will post 3.4599999 EPS for the current fiscal year.
In related news, Senior Officer Bradley John Fedorchuk sold 4,300 shares of the stock in a transaction dated Friday, May 7th. The shares were sold at an average price of C$36.33, for a total transaction of C$156,204.38. Following the sale, the insider now directly owns 779 shares of the company's stock, valued at approximately C$28,298.42.
About Great-West Lifeco
Great-West Lifeco Inc, a financial services holding company, engages in the life and health insurance, retirement and investment services, asset management, and reinsurance businesses in Canada, the United States, and Europe. The company offers a portfolio of financial and benefit plan solutions for individuals, families, businesses, and organizations; life, disability, critical illness, accidental death, dismemberment, health and dental protection, and creditor insurance products; and wealth savings and income, accumulation, and annuity products.
Further Reading: What is the market perform rating?
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Before you consider Great-West Lifeco, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Great-West Lifeco wasn't on the list.
While Great-West Lifeco currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The 5 Stocks Here